Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.15 +0.01 (+0.87%)
As of: Oct 21, 2026 · 11:13 AM EDT

Acurx Pharmaceuticals (ACXP) Share-based Compensation (2020 - 2026)

Updated

Acurx Pharmaceuticals' Share-based Compensation was $200,537 in Q2 2026, down 38.1% from $324,216 a year earlier and down 22.4% from the prior quarter.

Analysis

Acurx Pharmaceuticals (ACXP) Share-based Compensation (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Acurx Pharmaceuticals' Share-based Compensation was $1.05 million through Jun 30, 2026, down 22.2% year-over-year; for FY2025, it came in at $1.25 million, down 52.1% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $2.6 million in FY2024 (-18.9%), $3.21 million in FY2023 (+11.7%), $2.87 million in FY2022 (-44.3%) and $5.15 million in FY2021 (+559.4%).
  • The Q2 2026 figure marks the lowest quarterly Share-based Compensation in data going back to Q1 2021.
  • Compared with a year earlier, Share-based Compensation has declined for eight straight quarters, with an average decline of 42.2% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q2 2024 (growth of 26.1%); the worst was Q2 2025 (a decline of 68.1%).
  • Per Business Quant data, ACXP's Share-based Compensation in the three quarters before Q2 2026 was $258,287 (Q1 2026), $294,794 (Q4 2025) and $294,793 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 166.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 249.00 Mn
10 Acurx Pharmaceuticals 4.90 Mn -28.56 Mn - 200,537.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,537.00
Mar 31, 2026 258,287.00
Dec 31, 2025 294,794.00
Sep 30, 2025 294,793.00
Jun 30, 2025 324,216.00
Mar 31, 2025 333,598.00
Dec 31, 2024 345,191.00
Sep 30, 2024 345,191.00
Jun 30, 2024 1.02 Mn
Mar 31, 2024 894,523.00
Dec 31, 2023 833,285.00
Sep 30, 2023 833,285.00
Jun 30, 2023 806,485.00
Mar 31, 2023 733,472.00
Dec 31, 2022 696,965.00
Sep 30, 2022 696,965.00
Jun 30, 2022 716,682.00
Mar 31, 2022 761,069.00
Dec 31, 2021 672,636.00
Jun 30, 2021 563,889.00
API Access

Acurx Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ACXP&period=max&api_key=YOUR_API_KEY